MNPR — Monopar Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Monopar Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	20.3	13.1	7.27	60.2	140
Total Other Current Assets
Total Current Assets	20.5	13.2	7.33	60.3	140
Net Property, Plant And Equipment	—	0.061	0.013	0	0.255
Other Long Term Assets
Total Assets	20.5	13.2	7.35	60.3	141
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	1.58	3.13	1.76	5.25	2.74
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.58	3.14	1.76	5.25	2.89
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	18.9	10.1	5.59	55	138
Total Liabilities & Shareholders' Equity	20.5	13.2	7.35	60.3	141
Total Common Shares Outstanding